Adamis Pharmaceuticals Corporation
Formulation including a combination of beta-endorphin and adrenocorticotropic hormone
Last updated:
Abstract:
The present specification provides compositions of .beta.-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
Status:
Grant
Type:
Utility
Filling date:
31 Aug 2020
Issue date:
29 Mar 2022